Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from EMPEROR-reduced - Zannad, Faiez; Ferreira, João Pedro; Pocock, Stuart J.; Zeller, Cordula; Anker, Stefan D.; Butler, Javed; Filippatos, Gerasimos; Hauske, Sibylle J.; Brückmann, Martina; Pfarr, Egon; Schnee, Janet; Wanner, Christoph; et al. (Circulation, 2021)
Gesehen am 08.07.2021